|
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
|
5R01CA135405-11
|
$290,592
|
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
5UG3CA211415-02
|
$338,933
|
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Exploiting the immune response to detect pathogen-induced cancers
|
5R01CA199948-04
|
$492,377
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-04
|
$612,939
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Georgia CaRes
|
5UG1CA189851-05
|
$875,025
|
|
GHAMANDE, SHARAD
|
AUGUSTA UNIVERSITY
|
|
Role of heat shock transcription factor HSF1 in tumoroginesis
|
5R01CA062130-23
|
$556,510
|
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
IDO-Expressing Immunoregulatory Dendritic Cells
|
5R01CA103320-15
|
$307,800
|
|
MUNN, DAVID
|
AUGUSTA UNIVERSITY
|
|
Identification of clonal DNA methylation and chromatin accessibility
|
5R03CA212829-02
|
$76,000
|
|
SHI, HUIDONG
|
AUGUSTA UNIVERSITY
|
|
NCI Community Oncology Research Program (NCORP) - Community Sites
|
5UG1CA190140-05
|
$1,188,290
|
|
SAPHNER, THOMAS
|
AURORA HEALTH CARE, INC.
|
|
High Resolution High Throughput Proteomics Platform for Cancer Research
|
5R33CA217699-02
|
$416,522
|
|
IBRAHIM, YEHIA
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
BCM Oncology Scholars Training Program
|
5T32CA174647-05
|
$258,995
|
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF
|
5R01CA193321-04
|
$362,569
|
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
De facto Target of Histone Deacetylase Inhibitors
|
5R21CA215591-02
|
$172,369
|
|
SUN, ZHENG
|
BAYLOR COLLEGE OF MEDICINE
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
5R01CA181572-05
|
$319,735
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-03
|
$215,047
|
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
|
5R01CA178387-05
|
$317,475
|
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting microRNAs to eradicate leukemia stem cells
|
5R01CA205247-02
|
$450,769
|
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
FEN1-mediated Okazaki fragment maturation and its deficiency in cancer
|
5R01CA073764-22
|
$369,788
|
|
SHEN, BINGHUI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Regulation of Ionizing Radiation-Induced DNA Damage Response
|
5R01CA130899-10
|
$382,500
|
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-11
|
$382,500
|
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
SOX9 Mediation of AR and ERG Driven Prostate Cancer
|
5R01CA168393-05
|
$361,050
|
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-04
|
$398,025
|
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of extracellular matrix mediated drug resistance
|
5R00CA180221-05
|
$248,999
|
|
MURANEN, TARU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Tumor Suppressive Pathways for Cancer Therapy
|
5R35CA197529-04
|
$1,044,000
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of regulation by RNA in acute myeloid leukemia
|
5R35CA197697-04
|
$1,042,185
|
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
|
5R01CA200671-03
|
$395,738
|
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of m6A mRNA methylation in Neuroblastoma
|
5R21CA219352-02
|
$191,227
|
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Cancer Deep Phenotype Extraction from Electronic Medical Records
|
5U24CA184407-06
|
$993,015
|
|
SAVOVA, GUERGANA
|
BOSTON CHILDREN'S HOSPITAL
|
|
National Research Mentoring Network for a Diverse Biomedical Workforce
|
5U54GM119023-05
|
$487,159
|
|
PFUND, CHRISTINE
|
BOSTON COLLEGE
|
|
Role of c-Cbl in Colon cancer
|
5R01CA175382-05
|
$361,050
|
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
|
5R01CA138509-10
|
$368,325
|
|
REINHARD, BJOERN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Accelerating Cancer Genomics with Cloud-scale Bioconductor
|
5U01CA214846-02
|
$438,654
|
|
CAREY, VINCENT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-10
|
$3,474,603
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma
|
5R21CA209940-02
|
$175,001
|
|
POCHET, NATHALIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the HSF1 Cancer Network
|
5R01CA194005-03
|
$406,031
|
|
SANTAGATA, SANDRO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum
|
5R44CA192588-04
|
$234,573
|
|
YANG, DERSHUNG
|
BRIGHTOUTCOME INC.
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-03
|
$518,165
|
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
Breast Cancer Locator
|
5R44CA210810-04
|
$969,868
|
|
KRISHNASWAMY, VENKATARAMANAN
|
CAIRNSURGICAL, INC.
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
5F31CA213965-02
|
$44,524
|
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Genetic Determinants of Barretts Esophagus and Esophageal Adenocarcinoma
|
5U54CA163060-07
|
$1,283,594
|
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Computational Genomic Epidemiology of Cancer (CoGEC) Training Program
|
5T32CA094186-17
|
$280,737
|
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy
|
5R01CA181654-04
|
$374,305
|
|
NARLA, GOUTHAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations
|
5R01CA196643-03
|
$383,725
|
|
WANG, ZHENGHE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
|
5R01CA218526-02
|
$384,283
|
|
DI VIZIO, DOLORES
|
CEDARS-SINAI MEDICAL CENTER
|
|
High resolution volumetric MRI for prostate cancer active surveillance
|
5R01CA217098-02
|
$379,039
|
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
|
5R01CA206220-03
|
$547,857
|
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors
|
5R01CA129822-08
|
$374,063
|
|
MEDINA-KAUWE, LALI
|
CEDARS-SINAI MEDICAL CENTER
|
Total relevant funding to Interferon for this search: $4,542,084
|